Repros Therapeutics Inc. Approved for Trading on Nasdaq Capital Market

THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqCM:RPRX) today announced that Nasdaq has granted the Company until May 5, 2010 to meet the continued listing requirements of the Nasdaq Capital Market. Repros began trading on the Nasdaq Capital Market on January 14, 2010. Nasdaq noted the progress made by Repros in resolving creditor debt, as well as the progress the Company has made in executing the plan to regain compliance that was presented to the Appeals Committee in December if the Company was allowed to move to the Nasdaq Capital Markets as part of its decision to allow the Company the additional time.